SMART ABL-364

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameSMART ABL-364
Drug Alias NameSDZ-ABL-364ABL-364
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis AgPdl Biopharma IncSandoz Pharmaceuticals Ag
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A